Articles
Page 5 of 25
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O1
-
Neutral endopeptidase inhibitors SOL-1 and candoxatril counteract kidney fibrosis by reducing myofibroblast formation in mouse UUO model
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P1 -
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O2 -
Hydroxyurea reduces leukocyte interactions with the vessel wall in a haemolytic mouse model via a possible NO/cGMP-mediated effect
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P2 -
Abstract not submitted for publication
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O3 -
What have genome-wide association studies taught us about cGMP and blood pressure regulation?
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O5 -
Effects of omeprazole and AlOH/MgOH on riociguat absorption
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P6 -
Pulmonary vascular adaptation to high-altitude living
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O9 -
G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P11 -
Conformational changes involved in sGC activation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O12 -
Identification and quantitation of 2´,3´-cGMP in murine tissues
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P12 -
Receptor guanylyl cyclase-G is a novel thermosensor in Grueneberg ganglion neurons involved in coolness-induced ultrasonic distress calls in mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P14 -
The soluble guanylyl cyclase activator BAY 60-2770 ameliorates detrusor dysfunction in obese mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P18 -
Mechanisms driving heme insertion into apo-sGC during its maturation in cells
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O18 -
New mechanisms of normoxic and hypoxic cGMP signalling mediated by the nitrite anion
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O20 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P21 -
Thiol-redox proteins interact with soluble guanylyl cyclase and modulate its activity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O21 -
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P23 -
Elementary Ca2+signals through endothelial TRPV4 channels regulate vascular function
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O23 -
Guanylyl cyclase-B plays an important role in adipogenesis and “browning” of white fat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P24 -
Natriuretic peptides and fat metabolism
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O24 -
PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P26 -
The role of VASP in cGMP-mediated vascular smooth muscle relaxation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P28 -
GUCY2C at the intersection of obesity and colorectal cancer
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O28 -
Cyclic GMP-mediated intercellular communication in mammalian ovarian follicles
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P31 -
Phosphodiesterase 5 is main regulator of brown adipocyte differentiation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P32 -
NO-H2S interactions involve cGMP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O32 -
Crystal structures of the carboxyl cGMP binding domain of plasmodium falciparumcGMP-dependent protein kinase reveals a novel salt bridge crucial for activation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P33 -
A novel physiological significance of natriuretic peptides in cancer metastasis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O34 -
A bone overgrowth disorder due to a gain-of-function mutation in the kinase homology domain of guanylyl cyclase B, the receptor for CNP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P35 -
Dual actions of ANP on endothelial permeability
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O35 -
Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P36 -
A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P38 -
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O38 -
Evidence for functional coupling of cGMP/cGKI signalling and TRPC channels in endothelium but not in vascular smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P40 -
Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P55 -
Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P57 -
In striatum phosphodiesterase 10A is part of a synaptic signalling complex
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P59 -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P61 -
Fishing for elusive cCMP-degrading phosphodiesterases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P62 -
Function of cGMP-dependent protein kinase II in volume expansion-induced diuresis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P63 -
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P65 -
Krait natriuretic peptide (KNP): a non-classical NP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P67 -
Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P68 -
Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P69 -
Receptor guanylyl cyclase B-mediated cGMP signalling controls axon bifurcation of cranial sensory ganglion neurons at the embryonic hindbrain
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P71 -
Endothelial GC-A can be a therapeutic target for metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P73 -
The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P75 -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P76 -
Anti-interleukin-6 therapy for treatment of high platelet counts in cGMP-dependent protein kinase I gene-targeted mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P80
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2023 Speed
57 days submission to first editorial decision for all manuscripts (Median)
178 days submission to accept (Median)2023 Usage
790,731 downloads
400 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication